Top 10 Questions and Answers From the National Clinician Consultation Center: What is Coming Up for Clinicians Across the United States [0.03%]
全美临床咨询中心十大问题解答：美国各地临床医生未来需要注意什么？
Parya Saberi,Carolyn Chu
Parya Saberi
The National Clinician Consultation Center (NCCC) has operated for the past 30 years as a federally supported educational resource for US clinicians, addressing a wide range of questions regarding HIV and viral hepatitis care. Changes in pr...
Updates on Testing, Treatment, and Prevention of Sexually Transmitted Infections in the United States, 2025 [0.03%]
2025年美国性传播感染的检测、治疗和预防最新进展
Caroline Katzman,Natalie Neu
Caroline Katzman
There has been a substantial increase in the prevalence of sexually transmitted infections (STIs) and a widening gap in health care disparities over the past decade. New technologies, emerging public health research, and growing antimicrobi...
Emily A Min,Philip Bolduc
Emily A Min
The primary care clinician can play a substantial role in the management and prevention of viral hepatitis infections, which cause a substantial burden of hepatocellular carcinoma and cirrhosis worldwide and in the US. One-time hepatitis B ...
Brian P Epling,Elizabeth Laidlaw,Christopher Dampier et al.
Brian P Epling et al.
Modern antiretroviral therapy has led to a dramatic reduction in HIV-associated opportunistic infections and mortality, but late diagnosis of HIV and poor linkage to care persist and lead to a worse prognosis. HIV care is now focused on ear...
Mario Stevenson
Mario Stevenson
The 2025 Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco maintained its existing format with a combination of plenary lectures, workshops, oral and poster abstract sessions, themed discussions, and interactiv...
CROI 2025: The Challenges of Sustaining Viral Suppression, Addressing Advanced HIV Disease, and Ending the HIV Epidemic Targets [0.03%]
CROI 2025：持续病毒抑制、应对晚期艾滋病病情以及实现终结艾滋病流行目标所面临的挑战
Shauna H Gunaratne,Hong-Van Tieu,Timothy J Wilkin et al.
Shauna H Gunaratne et al.
Important new data were presented at the 2025 Conference on Retroviruses and Opportunistic Infections. Mathematic models predicted a reversal of progress toward Ending the HIV Epidemic metrics if funding is discontinued. Interventions that ...
Sudipa Sarkar,Todd T Brown
Sudipa Sarkar
Aging-related comorbid conditions have major effects on health, quality of life, and survival in people with HIV (PWH). The 2025 Conference on Retroviruses and Opportunistic Infections (CROI) featured numerous studies about comorbid disease...
Annukka A R Antar,Michael J Peluso
Annukka A R Antar
New research on acute and postacute COVID-19 was presented at the 2025 Conference on Retroviruses and Opportunistic Infections (CROI). Results of the SCORPIO-PEP (Stopping COVID-19 Progression With Early Protease Inhibitor Treatment-Postexp...
CROI 2025: global epidemiology and prevention of HIV and other sexually transmitted diseases [0.03%]
2025 CROI：HIV及其他性传播疾病的全球流行病学和预防
Susan P Buchbinder,Albert Y Liu
Susan P Buchbinder
At the 2025 Conference on Retroviruses and Opportunistic Infections (CROI), investigators presented updates on the global HIV epidemic. Although new HIV infections have been declining globally, new infections are expanding in Eastern Europe...
CROI 2025: tuberculosis, Mpox, and other infectious complications in people with HIV [0.03%]
2025年CROI会议：HIV患者中的结核病、马波斯痘和其他感染并发症
Andrew D Kerkhoff,Jason Zucker,Diane V Havlir
Andrew D Kerkhoff
Updated strategies and new insights into tuberculosis and mpox treatment were a major focus at the 2025 Conference on Retroviruses and Opportunistic Infections, headlined by findings that high-dose rifampicin plus levofloxacin increased ear...